SCHEMBL197282

SCHEMBL197282

CC(=O)Nc1ccc(Cl)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.67
HTT P42858 3/20 0.67
L3MBTL1 Q9Y468 1/20 0.67
KMT2A Q03164 7/20 0.66
MEN1 O00255 6/20 0.66
EPHX1 P07099 1/20 0.66
MAPT P10636 3/20 0.64
ALDH1A1 P00352 2/20 0.64
TDP1 Q9NUW8 2/20 0.64
TSHR P16473 2/20 0.64
CA12 O43570 1/20 0.64
BRD4 O60885 1/20 0.64
NR1I2 O75469 1/20 0.64
CA1 P00915 1/20 0.64
CA2 P00918 1/20 0.64
MB P02144 1/20 0.64
CYP1A1 P04798 1/20 0.64
CA3 P07451 1/20 0.64
CYP3A4 P08684 1/20 0.64
RARG P13631 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9486219 0.98 SMN1; SMN2 (0.64) SMN1; SMN2HTTL3MBTL1KMT2AMEN1
SCHEMBL14384589 0.94 SMN1; SMN2 (0.79) SMN1; SMN2HTTL3MBTL1KMT2AMEN1
Phosphonic Acid SCHEMBL10340566 0.92 KMT2A (0.58) SMN1; SMN2HTTL3MBTL1KMT2AMEN1
SCHEMBL4743252 0.90 ALDH1A1 (0.70) SMN1; SMN2HTTL3MBTL1KMT2AMEN1
SCHEMBL10921326 0.88 MEN1 (0.55) SMN1; SMN2HTTL3MBTL1KMT2AMEN1
SCHEMBL11656245 0.88 KMT2A (0.69) SMN1; SMN2HTTL3MBTL1KMT2AMEN1
SCHEMBL861674 0.87 SMN1; SMN2 (0.84) SMN1; SMN2HTTL3MBTL1KMT2AMEN1
SCHEMBL8896479 0.87 EPHX1 (0.57) SMN1; SMN2HTTL3MBTL1KMT2AMEN1
SCHEMBL10922613 0.87 PKM (0.72) KMT2AMEN1ALDH1A1CA12CA1
Hydrochloric Acid SCHEMBL8896309 0.85 EPHX1 (0.56) SMN1; SMN2HTTL3MBTL1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 613 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118290353-A Preparation method of stable isotope labeled diazepam 司法鉴定科学研究院 2024-07-05 CN claimed
CN-117347533-B Method for detecting related substances of compound paracetamol and renin tablets for children 山东则正医药技术有限公司 2024-04-19 CN claimed
CN-117347533-A Method for detecting related substances of compound paracetamol and renin tablets for children 山东则正医药技术有限公司 2024-01-05 CN claimed
CN-113999130-B Preparation method of o-nitroanilide compound 湖北工业大学 2023-09-29 CN claimed
CN-115996911-A Substituted N-phenylacetamides having P2X4 receptor antagonistic activity 拜耳公司 2023-04-21 CN claimed
CN-111606820-B Preparation method of N-iodobenzene-N-phenylamide compound 湖北工业大学 2023-03-31 CN claimed
CN-114832799-B Preparation and application of carbon-point bonded silica gel chromatographic stationary phase based on eutectic solvent 中国科学院兰州化学物理研究所 2023-02-28 CN claimed
CN-115097049-A Method for determining related substances in pediatric paracetamol, atificial cow-bezoar and chlorphenamine maleate granules 广西壮族自治区食品药品检验所 2022-09-23 CN claimed
US-20220274926-A1 IMMUNOREGULATORY AGENTS FLEXUS BIOSCIENCES INC (US) 2022-09-01 US claimed
CN-114965754-A Method for detecting related substances and bacteriostatic agent in acetaminophen tablet 陕西必康制药集团控股有限公司 2022-08-30 CN claimed
WO-2007070818-A1 SIX-MEMBERED HETEROCYCLES USEFUL AS SERINE PROTEASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-06-21 WO claimed
WO-2007070816-A2 THIOPHENE DERIVATIVES AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-06-21 WO claimed
US-20060058553-A1 Novel bicyclic hydroxamates as inhibitors of histone deacetylase AXYS PHARMACEUTICALS, INC. (US) 2006-03-16 US claimed
EP-1472216-A2 NOVEL BICYCLIC HYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE Axys Pharmaceuticals (US) 2004-11-03 EP claimed
US-6794383-B2 Heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseases TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-09-21 US claimed
WO-2003066579-A2 NOVEL BICYCLIC HYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE AXYS PHARMACEUTICALS (US) 2003-08-14 WO claimed
EP-0470669-B1 Preparation of fluorophenols, fluorohalophenols, N-acylfluoroanilines, and N-acylfluorohaloanilines DOWELANCO (US) 1997-11-12 EP claimed
EP-0470669-A2 Preparation of fluorophenols, fluorohalophenols, N-acylfluoroanilines, and N-acylfluorohaloanilines DOWELANCO (US) 1992-02-12 EP claimed
EP-0331052-A2 Process for the preparation of imidized acrylic polymers ELF ATOCHEM ITALIA S.r.l. (IT) 1989-09-06 EP claimed
EP-0315151-A2 Process for the preparation of imidized acrylic polymers ELF ATOCHEM ITALIA S.r.l. (IT) 1989-05-10 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220274926-A1 IMMUNOREGULATORY AGENTS IDO1, IDO2, INMT SMN1; SMN2 4584/4885HTT 3224/4885L3MBTL1 3766/4885
US-20060058553-A1 Novel bicyclic hydroxamates as inhibitors of histone deacetylase HDAC1, HDAC2, HDAC11 SMN1; SMN2 2943/4885HTT 293/4885L3MBTL1 2451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.